Nutex Health Inc. (NUTX)
Nutex Health Statistics
Share Statistics
Nutex Health has 5.44M shares outstanding. The number of shares has increased by -99.27% in one year.
| Shares Outstanding | 5.44M |
| Shares Change (YoY) | -99.27% |
| Shares Change (QoQ) | 7.33% |
| Owned by Institutions (%) | 0.26% |
| Shares Floating | 3.26M |
| Failed to Deliver (FTD) Shares | 4.55K |
| FTD / Avg. Volume | 10.83% |
Short Selling Information
The latest short interest is 51.52K, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 51.52K |
| Short % of Shares Out | 0.95% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 1.99 |
Valuation Ratios
The PE ratio is -2.6 and the forward PE ratio is 20.09. Nutex Health's PEG ratio is -1.77.
| PE Ratio | -2.6 |
| Forward PE | 20.09 |
| PS Ratio | 0.48 |
| Forward PS | 0.7 |
| PB Ratio | 1.94 |
| P/FCF Ratio | -14.44 |
| PEG Ratio | -1.77 |
Enterprise Valuation
Nutex Health Inc. has an Enterprise Value (EV) of 2.04B.
| EV / Earnings | -44.54 |
| EV / Sales | 8.23 |
| EV / EBITDA | -139.84 |
| EV / EBIT | -64.18 |
| EV / FCF | -247.46 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 4.49.
| Current Ratio | 1.56 |
| Quick Ratio | 1.5 |
| Debt / Equity | 4.49 |
| Total Debt / Capitalization | 81.78 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -1.95 |
Financial Efficiency
Return on equity (ROE) is -0.75% and return on capital (ROIC) is -8.02%.
| Return on Equity (ROE) | -0.75% |
| Return on Assets (ROA) | -0.11% |
| Return on Capital (ROIC) | -8.02% |
| Revenue Per Employee | $309,557.9 |
| Profits Per Employee | $-57,233.27 |
| Employee Count | 800 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 62.78 |
Taxes
| Income Tax | -5.07M |
| Effective Tax Rate | 0.1 |
Stock Price Statistics
The stock price has increased by 261.71% in the last 52 weeks. The beta is 2.22, so Nutex Health's price volatility has been higher than the market average.
| Beta | 2.22 |
| 52-Week Price Change | 261.71% |
| 50-Day Moving Average | 51.72 |
| 200-Day Moving Average | 28.5 |
| Relative Strength Index (RSI) | 48.16 |
| Average Volume (20 Days) | 42.05K |
Income Statement
In the last 12 months, Nutex Health had revenue of 247.65M and earned -45.79M in profits. Earnings per share was -10.39.
| Revenue | 247.65M |
| Gross Profit | 34.77M |
| Operating Income | -31.77M |
| Net Income | -45.79M |
| EBITDA | -14.58M |
| EBIT | -31.77M |
| Earnings Per Share (EPS) | -10.39 |
Balance Sheet
The company has 22M in cash and 275.76M in debt, giving a net cash position of -253.75M.
| Cash & Cash Equivalents | 22M |
| Total Debt | 275.76M |
| Net Cash | -253.75M |
| Retained Earnings | -409.07M |
| Total Assets | 438.49M |
| Working Capital | 52.24M |
Cash Flow
In the last 12 months, operating cash flow was 1.26M and capital expenditures -9.5M, giving a free cash flow of -8.24M.
| Operating Cash Flow | 1.26M |
| Capital Expenditures | -9.5M |
| Free Cash Flow | -8.24M |
| FCF Per Share | -1.87 |
Margins
Gross margin is 14.04%, with operating and profit margins of -12.83% and -18.49%.
| Gross Margin | 14.04% |
| Operating Margin | -12.83% |
| Pretax Margin | -19.58% |
| Profit Margin | -18.49% |
| EBITDA Margin | -5.89% |
| EBIT Margin | -12.83% |
| FCF Margin | -3.33% |
Dividends & Yields
NUTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -19.96% |
| FCF Yield | -2.91% |
Analyst Forecast
The average price target for NUTX is $67.5, which is 29.7% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.5 |
| Price Target Difference | 29.7% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Jul 3, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 3, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -0.1 |
| Piotroski F-Score | 6 |